Publicité
Marchés français ouverture 6 h 10 min

  • Dow Jones

    38 085,80
    -375,12 (-0,98 %)
     

  • Nasdaq

    15 611,76
    -100,99 (-0,64 %)
     

  • Nikkei 225

    37 607,71
    -20,77 (-0,06 %)
     

  • EUR/USD

    1,0731
    -0,0002 (-0,02 %)
     

  • HANG SENG

    17 284,54
    +83,27 (+0,48 %)
     

  • Bitcoin EUR

    59 853,62
    -372,72 (-0,62 %)
     

  • CMC Crypto 200

    1 386,74
    +4,17 (+0,30 %)
     

  • S&P 500

    5 048,42
    -23,21 (-0,46 %)
     

Data Science Impacting the Pharmaceutical Industry Part II: Clinical trial Applications

ReportLinker
·1 min de lecture

Clinical Trials, the most crucial step in drug discovery has never been in the forefront in adopting new technologies and transforming from the conventional protocols. With the development of AI/ML in the last five years, it has opened up a new horizon for transforming clinical trials.

New York, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Data Science Impacting the Pharmaceutical Industry Part II: Clinical trial Applications" - https://www.reportlinker.com/p05974249/?utm_source=GNW


It has been proven that use of AI/ML tools can scan through large volumes of data and provide accurate results within minutes which takes enormous time when performed by humans. Application of analytical tools help identify trends and patterns that may have been difficult to observe otherwise and provide results in the best possible way.
Read the full report: https://www.reportlinker.com/p05974249/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001